Journal info


6 times a year.
Founded: 1954
ISSN 0028-2685
ISSN 1338-4317 (online)

Published in English

Editorial Info
Abstracted and Indexed
Submission Guidelines

Select Journal







Webshop Cart

Your Cart is currently empty.

Info: Your browser does not accept cookies. To put products into your cart and purchase them you need to enable cookies.

2018

FOXA1 and CK7 expression in esophageal squamous cell carcinoma and its prognostic significance
Authors: Y. XU, W. WANG, L. LI, J. LIU, X. WU, J. YU, H. WANG, W. CUI, R. ZHANG
Neoplasma Vol.65, No.3, p.469-476, 2018
doi:10.4149/neo_2018_170529N384
[View Abstract]


Diagnosis of carcinoma of unknown primary site with the aid of simple PCR tests: a single-center experience
Authors: E. SUSPITSIN, G. YANUS, E. IMYANITOV
Neoplasma Vol.65, No.3, p.461-468, 2018
doi:10.4149/neo_2018_170423N304
[View Abstract]


AFP role in predicting recurrence of hepatocellular carcinoma after living donor liver transplantation in HCV patients
Authors: A. L. KOMOROWSKI, C.-C. HSU, K. D. JULKA, B. VASAVADA, C.-C. LIN, C.-C. WANG, C.-L. CHEN
Neoplasma Vol.65, No.3, p.455-460, 2018
doi:10.4149/neo_2018_170315N184
[View Abstract]


The current application of ACOSOG Z0011 trial results: Is further implementation of sentinel lymph node intra-operative histopathological examination mandatory in breast cancer patients – a single-center analysis
Authors: T. NOWIKIEWICZ, W. ZEGARSKI, K. PAGACZ, M. NOWACKI, A. MORAWIEC-SZTANDERA, I. GLOWACKA-MROTEK, M. SOWA, M. BIEDKA, A. KOLACINSKA
Neoplasma Vol.65, No.3, p.449-454, 2018
doi:10.4149/neo_2018_170321N202
[View Abstract]


HPV status and its genomic integration affect survival of patients with cervical cancer
Authors: M. IBRAGIMOVA, M. TSYGANOV, O. SHPILEVA, O. CHURUKSAEVA, V. BYCHKOV, L. KOLOMIETS, N. LITVIAKOV
Neoplasma Vol.65, No.3, p.441-448, 2018
doi:10.4149/neo_2018_170414N277
[View Abstract]


Hashimoto’s thyroiditis, nodular goiter or follicular adenoma combined with papillary thyroid carcinoma play protective role in patients
Authors: H. MA, L. LI, K. LI, T. WANG, Y. ZHANG, C. ZHANG, Y. XU, X. WU, J. YU, H. WANG, B. XIANG, W. WANG, R. ZHANG
Neoplasma Vol.65, No.3, p.436-440, 2018
doi:10.4149/neo_2018_170428N317
[View Abstract]


Human Cytomegalovirus (HCMV) infection was not correlated with overall survival in glioblastomas
Authors: S. HAN, P. F. WANG, Y. X. XING, H. W. SONG, K. YAO, Z. X. LIN
Neoplasma Vol.65, No.3, p.431-435, 2018
doi:10.4149/neo_2018_170124N59
[View Abstract]


Dynamics of high risk clinical target volume reduction during brachytherapy and impact on its coverage in patients with inoperable cervical cancer
Authors: M. POBIJAKOVA, D. SCEPANOVIC, M. PALUGA, M. FEKETE, J. MARDIAK
Neoplasma Vol.65, No.3, p.425-430, 2018
doi:10.4149/neo_2018_170113N30
[View Abstract]


Novel insights into transcriptional dysregulation in colorectal cancer
Authors: Y. FEODOROVA, D. TASHKOVA, I. KOEV, A. TODOROV, G. KOSTOV, K. SIMITCHIEV, V. BELOVEJDOV, R. DIMOV, V. SARAFIAN
Neoplasma Vol.65, No.3, p.415-424, 2018
doi:10.4149/neo_2018_170707N467
[View Abstract]


miR-483 is down-regulated in gastric cancer and suppresses cell proliferation, invasion and protein O-GlcNAcylation by targeting OGT
Authors: F. Y. YU, C. Y. ZHOU, Y. B. LIU, B. WANG, L. MAO, Y. LI
Neoplasma Vol.65, No.3, p.406-414, 2018
doi:10.4149/neo_2018_170608N411
[View Abstract]


Evaluation of overall survival rate of different therapies in the treatment of T1–T3 prostate cancer: a network meta-analysis
Authors: S. Y. CHEN, Y. DU, Q. SHAO, J. S. LI, H. Y. CHEN
Neoplasma Vol.65, No.3, p.398-405, 2018
doi:10.4149/neo_2018_170419N288
[View Abstract]


Multiparametric MRI analysis of morphologico-functional features of DCIS – correlation with the grade of nuclear atypia
Authors: V. LEHOTSKA, K. RAUOVA, L. VANOVCANOVA
Neoplasma Vol.65, No.3, p.389-397, 2018
doi:10.4149/neo_2018_170509N333
[View Abstract]


Sulindac induces differentiation of glioblastoma stem cells making them more sensitive to oxidative stress
Authors: S. K. ALLANI, H. WEISSBACH, M. A. LOPEZ-TOLEDANO
Neoplasma Vol.65, No.3, p.376-388, 2018
doi:10.4149/neo_2018_170404N245
[View Abstract]


Tetramethylpyrazine (TMPZ) triggers S-phase arrest and mitochondria- dependent apoptosis in lung cancer cells
Authors: H. H. HUANG, F. B. LIU, Z. RUAN, J. ZHENG, Y. J. SU, J. WANG
Neoplasma Vol.65, No.3, p.367-375, 2018
doi:10.4149/neo_2018_170112N26
[View Abstract]


Identification of recurrent risk-related genes and establishment of support vector machine prediction model for gastric cancer
Authors: B. LIU, J. TAN, X. WANG, X. LIU
Neoplasma Vol.65, No.3, p.360-366, 2018
doi:10.4149/neo_2018_170507N326
[View Abstract]


Claudin-7 (CLDN7) is overexpressed in gastric cancer and promotes gastric cancer cell proliferation, invasion and maintains mesenchymal state
Authors: Z. WU, J. SHI, Y. SONG, J. ZHAO, J. SUN, X. CHEN, P. GAO, Z. WANG
Neoplasma Vol.65, No.3, p.349-359, 2018
doi:10.4149/neo_2018_170320N200
[View Abstract]


Three novel microRNAs based on microRNA signatures for gastric mucosa- associated lymphoid tissue lymphoma
Authors: Y. ZHANG, A. LIU, M. E, L. QUAN, Y. QU, A. GU
Neoplasma Vol.65, No.3, p.339-348, 2018
doi:10.4149/neo_2018_170208N89
[View Abstract]


miR-506 suppresses cervical cancer cell proliferation both in vitro and in vivo
Authors: M. GONG, C. CHEN, H. ZHAO, M. SUN, M. SONG
Neoplasma Vol.65, No.3, p.331-338, 2018
doi:10.4149/neo_2018_170112N25
[View Abstract]


Clinical characteristics and treatments of patients with alpha-fetoprotein producing gastric carcinoma
Authors: W. GONG, Y. SU, A. LIU, J. LIU, D. SUN, T. JIANG, J. XIANG, C. CHI, P. SUN
Neoplasma Vol.65, No.3, p.326-330, 2018
doi:10.4149/neo_2018_170207N84
[View Abstract]


Neovascularization in Ewing’s sarcoma
Authors: A. F. MAVROGENIS, C. T. VOTTIS, P. D. MEGALOIKONOMOS, G. D. AGROGIANNIS, S. THEOCHARIS
Neoplasma Vol.65, No.3, p.317-325, 2018
doi:10.4149/neo_2018_170410N264
Price: free access
[View Abstract]





Display #  
Results 41 - 60 of 100

© AEPress s.r.o
Copyright notice: For any permission to reproduce, archive or otherwise use the documents in the ELiS, please contact AEP.